熔点	118-120 ºC

安全说明书	S22;S24/25

来源	SDS样本
Alfa-Aesar	浏览或下载
TCI	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia.Hiroaki Shimizu et al.Leukemia research, 37(11), 1477-1481 (2013-09-24) Feasibility of azacitidine added to standard chemotherapy in older patients with acute myeloid leukemia--a randomised SAL pilot study.Utz Krug et al.PloS one, 7(12), e52695-e52695 (2013-01-10) Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia.Sarah Bertoli et al.Blood, 121(14), 2618-2626 (2013-02-01) Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.Steven E Coutre et al.British journal of haematology, 165(4), 497-503 (2014-02-18) High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.G M Marshall et al.Leukemia, 27(7), 1497-1503 (2013-02-15) Comparative endothelial profiling of doxorubicin and daunorubicin in cultured endothelial cells.Tomasz Wojcik et al.Toxicology in vitro : an international journal published in association with BIBRA, 29(3), 512-521 (2014-12-23) Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age.Carlos E Vigil et al.Leukemia research, 37(11), 1468-1471 (2013-09-10) Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States.Marko Kavcic et al.Cancer, 119(10), 1916-1923 (2013-02-26) Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.Eduard Jirkovský et al.Toxicology, 311(3), 191-204 (2013-07-09) PI-103 sensitizes acute myeloid leukemia stem cells to daunorubicin-induced cytotoxicity.Qian Ding et al.Medical oncology (Northwood, London, England), 30(1), 395-395 (2013-01-22) The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia.Lili Xiang et al.Annals of hematology, 92(8), 1063-1069 (2013-03-22) Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia.Luca Maurillo et al.American journal of hematology, 90(2), 125-131 (2014-11-08) Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin.Takuya Suzuki et al.International journal of pharmaceutics, 476(1-2), 205-212 (2014-10-05) Artesunate has its enhancement on antibacterial activity of β-lactams via increasing the antibiotic accumulation within methicillin-resistant Staphylococcus aureus (MRSA).Weiwei Jiang et al.The Journal of antibiotics, 66(6), 339-345 (2013-04-04) Biocompatible microemulsion modifies the tissue distribution of doxorubicin.Caroline Damico Candido et al.Journal of pharmaceutical sciences, 103(10), 3297-3301 (2014-08-08) Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cells.Petr Kosztyu et al.Chemico-biological interactions, 219, 203-210 (2014-06-24) A case report of acute myeloid leukemia after liver transplantation.Mingjuan Liu et al.Acta haematologica, 129(4), 225-228 (2013-01-09) Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status.Jae-Ho Yoon et al.American journal of hematology, 88(12), 1074-1081 (2013-08-29) Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation.Zhiyong Yu et al.Internal medicine (Tokyo, Japan), 52(6), 689-693 (2013-03-19) Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia.Sang Min Lee et al.Annals of hematology, 92(8), 1101-1110 (2013-04-06) Evidence for inhibition of growth related to compromised DNA synthesis in the interaction of daunorubicin with H-35 rat hepatoma.C Munger et al.Cancer research, 48(9), 2404-2411 (1988-05-01) Probing the relative orientation of molecules bound to DNA through controlled interference using second-harmonic generation.Benjamin Doughty et al.Proceedings of the National Academy of Sciences of the United States of America, 110(15), 5756-5758 (2013-03-27) Cancer cell detection based on the interaction between an anticancer drug and cell membrane components.Pranjal Chandra et al.Chemical communications (Cambridge, England), 49(19), 1900-1902 (2013-01-09) Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression.Kenichiro Doi et al.Cancer biology & therapy, 15(8), 1077-1086 (2014-05-21) Upregulation of drug transporter expression by osteopontin in prostate cancer cells.I-Shan Hsieh et al.Molecular pharmacology, 83(5), 968-977 (2013-02-26) High-dose cytarabine-based consolidation shows superior results for older AML patients with intermediate risk cytogenetics in first complete remission.Mona Hassanein et al.Leukemia research, 37(5), 556-560 (2013-01-30) Idarubicin appears equivalent to dose-intense daunorubicin for remission induction in patients with acute myeloid leukemia.Steven Trifilio et al.Leukemia research, 37(8), 868-871 (2013-06-04) Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis.G Gausdal et al.Cell death & disease, 4, e516-e516 (2013-03-02) Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.Jessica L Heath et al.Pediatric blood & cancer, 61(10), 1874-1876 (2014-06-04) Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia.Yanyan Mei et al.Cancer science, 105(4), 463-472 (2014-04-12) Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program.Hernan Carol et al.Pediatric blood & cancer, 62(1), 65-71 (2014-09-10) Microgravity Modulates Effects of Chemotherapeutic Drugs on Cancer Cell Migration.Devika Prasanth et al.Life (Basel, Switzerland), 10(9) (2020-08-28) Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis.Oliver Teuffel et al.British journal of haematology, 161(2), 192-203 (2013-02-13) Nasolacrimal system obstruction, ptosis and esotropia due to chemotherapy in acute lymphoblastic leukemia.Oktay Esmer et al.Cutaneous and ocular toxicology, 32(4), 330-332 (2013-03-07) Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.Robert S Nickel et al.Pediatric blood & cancer, 61(5), 810-814 (2013-12-21) Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resistant human leukemic cell line HL-60.Yuping Gong et al.The Journal of biological chemistry, 278(50), 50234-50239 (2003-10-03) S-nitrosoglutathione covalently modifies cysteine residues of human carbonyl reductase 1 and affects its activity.Tereza Hartmanová et al.Chemico-biological interactions, 202(1-3), 136-145 (2013-01-09) Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).Michael E Rytting et al.Cancer, 120(23), 3660-3668 (2014-07-22) The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents.Cedric Dos Santos et al.Blood, 122(11), 1900-1913 (2013-07-31) Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3.Jakub Hofman et al.Toxicology and applied pharmacology, 278(3), 238-248 (2014-05-17) EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells.Anna Rommer et al.PloS one, 8(2), e56308-e56308 (2013-03-05) Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group.Gertjan J L Kaspers et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(5), 599-607 (2013-01-16) Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004.Ursula Creutzig et al.Blood, 122(1), 37-43 (2013-05-25) Binding of daunomycin to DNA and the inhibition of RNA and DNA synthesis.N S Mizuno et al.Cancer research, 35(6), 1542-1546 (1975-06-01) Acute myeloid leukemia in first remission: to choose transplantation or not?Richard M Stone Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(10), 1262-1266 (2013-02-27) Comparison of 60 or 90 mg/m(2) of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics.Raynier Devillier et al.American journal of hematology, 90(2), E29-E30 (2014-11-05) In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein.E J Wang et al.Drug metabolism and disposition: the biological fate of chemicals, 28(5), 522-528 (2000-04-20) Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.Sarah A Buckley et al.American journal of hematology, 89(4), 423-428 (2014-01-03) A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells.Meejeon Roh et al.PloS one, 3(7), e2572-e2572 (2008-07-04) Mutant DNMT3A clone evading chemotherapy and infiltrating central nervous system in a patient with molecularly good-risk acute myeloid leukemia.Yi-Yang Chen et al.Annals of hematology, 93(8), 1441-1442 (2013-12-18) Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system.Jay Chhablani et al.Investigative ophthalmology & visual science, 54(2), 1268-1279 (2013-01-17) Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy.Rocky Pramanik et al.Leukemia research, 37(5), 503-509 (2013-01-22) Ewing sarcoma arising after treatment of diffuse large B-cell lymphoma.Nobuhiro Hiramoto et al.Japanese journal of clinical oncology, 43(4), 417-421 (2013-03-12) Epigenetic regulation of tissue factor inducibility in endothelial cell senescence.David J Kurz et al.Mechanisms of ageing and development, 140, 1-9 (2014-07-20) Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase.Ingrid Jakobsen Falk et al.American journal of hematology, 88(12), 1001-1006 (2013-07-23) 2D- and 3D-QSAR studies of a series of benzopyranes and benzopyrano[3,4b][1,4]-oxazines as inhibitors of the multidrug transporter P-glycoprotein.Ishrat Jabeen et al.Journal of computer-aided molecular design, 27(2), 161-171 (2013-02-13) A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse.S Park et al.Leukemia, 27(7), 1479-1486 (2013-01-17) A correlation between cytotoxicity and reductase-mediated metabolism in cell lines treated with doxorubicin and daunorubicin.Onkar S Bains et al.The Journal of pharmacology and experimental therapeutics, 347(2), 375-387 (2013-09-03) Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.Antonio R Lucena-Araujo et al.Annals of hematology, 93(12), 2001-2010 (2014-07-02) High content screening identifies monensin as an EMT-selective cytotoxic compound.Marion Vanneste et al.Scientific reports, 9(1), 1200-1200 (2019-02-06) Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218.Daniel C Ferguson et al.Drug metabolism and disposition: the biological fate of chemicals, 43(7), 922-927 (2015-04-29) ERK Activity in Immature Leukemic Cells Drives Clonal Selection during Induction Therapy for Acute Myeloid Leukemia.Michal Hayun et al.Scientific reports, 10(1), 8349-8349 (2020-05-21) In vitro induction of apoptosis and necrosis by new derivatives of daunorubicin.Marta Stojak et al.Anticancer research, 33(10), 4439-4443 (2013-10-15) Binding of the plant alkaloid aristololactam-β-d-glucoside and antitumor antibiotic daunomycin to single stranded polyribonucleotides.Abhi Das et al.Biochimica et biophysica acta, 1830(10), 4708-4718 (2013-06-19) Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group.Etan Orgel et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(13), 1331-1337 (2014-04-02) Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML.Jorge E Cortes et al.Cancer, 121(2), 234-242 (2014-09-17) Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.Enrico De Astis et al.Annals of hematology, 93(12), 2011-2018 (2014-07-06) Orientia tsutsugamushi Strain Ikeda Ankyrin Repeat-Containing Proteins Recruit SCF1 Ubiquitin Ligase Machinery via Poxvirus-Like F-Box Motifs.Andrea R Beyer et al.Journal of bacteriology, 197(19), 3097-3109 (2015-07-15) Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.Sylvain Pilorge et al.American journal of hematology, 89(4), 399-403 (2014-01-01) Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression.Pengcheng Shi et al.Pharmacogenomics, 14(1), 17-23 (2012-12-21) Liposomes modified with p-aminophenyl-α-D-mannopyranoside: a promising delivery system in targeting the brain.Haisheng Peng et al.Therapeutic delivery, 4(12), 1475-1477 (2013-12-07) A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia.Stephen H Petersdorf et al.Blood, 121(24), 4854-4860 (2013-04-18) Post-chemotherapeutic resolution of acute myeloid leukaemia-induced gingival enlargement: a case report.S Singh-Rambiritch et al.SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging, 67(7), 344-347 (2013-08-21)

备注